Sepsis Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Sepsis Diagnostic Market, By Technology

7.1.  Sepsis Diagnostic Market, By Technology Type, 2020-2027

7.1.1.    Microbiology

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Molecular Diagnostics

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Immunoassays

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Flow Cytometry

7.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Sepsis Diagnostic Market, Pathogen

8.1.  Sepsis Diagnostic Market, Pathogen, 2020-2027

8.1.1.    Bacterial Sepsis

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Fungal Sepsis

8.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Sepsis Diagnostic Market, By Product

9.1.  Sepsis Diagnostic Market, By Filling Material, 2020-2027

9.1.1.    Instruments

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Blood Culture Media

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Assay Kits and Reagents

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Software

9.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Sepsis Diagnostic Market, By Testing Type

10.1.        Sepsis Diagnostic Market, By End-use, 2020-2027

10.1.1.  Laboratory Testing

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  PoC Testing

10.1.2.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global Sepsis Diagnostic Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Technology (2016-2027)

11.1.2.  Market Revenue and Forecast, Pathogen (2016-2027)

11.1.3.  Market Revenue and Forecast, By Product(2016-2027)

11.1.4.  Market Revenue and Forecast, By Testing Type(2016-2027)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.1.5.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.1.5.3.      Market Revenue and Forecast, By Product(2016-2027)

11.1.5.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.1.6.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.1.6.3.      Market Revenue and Forecast, By Product(2016-2027)

11.1.6.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Technology (2016-2027)

11.2.2.  Market Revenue and Forecast, Pathogen (2016-2027)

11.2.3.  Market Revenue and Forecast, By Product(2016-2027)

11.2.4.  Market Revenue and Forecast, By Testing Type(2016-2027)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.2.5.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.2.5.3.      Market Revenue and Forecast, By Product(2016-2027)

11.2.5.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.2.6.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.2.6.3.      Market Revenue and Forecast, By Product(2016-2027)

11.2.6.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.2.7.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.2.7.3.      Market Revenue and Forecast, By Product(2016-2027)

11.2.7.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.2.8.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.2.8.3.      Market Revenue and Forecast, By Product(2016-2027)

11.2.8.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Technology (2016-2027)

11.3.2.  Market Revenue and Forecast, Pathogen (2016-2027)

11.3.3.  Market Revenue and Forecast, By Product(2016-2027)

11.3.4.  Market Revenue and Forecast, By Testing Type(2016-2027)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.3.5.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.3.5.3.      Market Revenue and Forecast, By Product(2016-2027)

11.3.5.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.3.6.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.3.6.3.      Market Revenue and Forecast, By Product(2016-2027)

11.3.6.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.3.7.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.3.7.3.      Market Revenue and Forecast, By Product(2016-2027)

11.3.7.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.3.8.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.3.8.3.      Market Revenue and Forecast, By Product(2016-2027)

11.3.8.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Technology (2016-2027)

11.4.2.  Market Revenue and Forecast, Pathogen (2016-2027)

11.4.3.  Market Revenue and Forecast, By Product(2016-2027)

11.4.4.  Market Revenue and Forecast, By Testing Type(2016-2027)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.4.5.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.4.5.3.      Market Revenue and Forecast, By Product(2016-2027)

11.4.5.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.4.6.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.4.6.3.      Market Revenue and Forecast, By Product(2016-2027)

11.4.6.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.4.7.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.4.7.3.      Market Revenue and Forecast, By Product(2016-2027)

11.4.7.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.4.8.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.4.8.3.      Market Revenue and Forecast, By Product(2016-2027)

11.4.8.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Technology (2016-2027)

11.5.2.  Market Revenue and Forecast, Pathogen (2016-2027)

11.5.3.  Market Revenue and Forecast, By Product(2016-2027)

11.5.4.  Market Revenue and Forecast, By Testing Type(2016-2027)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.5.5.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.5.5.3.      Market Revenue and Forecast, By Product(2016-2027)

11.5.5.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Technology (2016-2027)

11.5.6.2.      Market Revenue and Forecast, Pathogen (2016-2027)

11.5.6.3.      Market Revenue and Forecast, By Product(2016-2027)

11.5.6.4.      Market Revenue and Forecast, By Testing Type(2016-2027)

Chapter 12.  Company Profiles

12.1.              bioMérieux SA

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Beckman Coulter, Inc

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Becton, Dickinson and Company

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Sysmex Corporation

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              F. Hoffmann-La Roche AG

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Thermo Fisher Scientific, Inc

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:37540
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:March 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers